Structure-based approaches to antibiotic drug discovery

Current Protocols in Microbiology

Volumn , Issue SUPPL. 12, 2009, Pages

  Nicola, George ^a   Abagyan, Ruben ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Computational biology; Structure based drug design; Virtual ligand screening

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN;

BACTERIAL INFECTION; DERIVATIZATION; DRUG DESIGN; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; HIGH THROUGHPUT SCREENING; MOLECULAR BIOLOGY; MOLECULAR IMAGING; MOLECULAR LIBRARY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURAL GENOMICS; STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS; X RAY CRYSTALLOGRAPHY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; COMPUTATIONAL BIOLOGY; DRUG DESIGN; DRUG DISCOVERY; GENOMICS; MODELS, MOLECULAR; PROTEOMICS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 61349115673     PISSN: 19348525     EISSN: 19348533     Source Type: Journal    
DOI: 10.1002/9780471729259.mc1702s12     Document Type: Review

References (34)

1. Abagyan, R. 2006. Problems in computational structural genomics. In Structural Genomics and High Throughput Structural Biology (M. Sundstrom, M. Norin, and A. Edwards, eds.) pp. 223-250. Taylor and Francis Group, CRC Press, Boca Raton, Fla.
2. Abagyan, R., Totrov, M., and Kuznetsov, D.A. 1994. ICM: A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation. J. Comput. Chem. 15:488-506.
3. An, J., Totrov, M., and Abagyan, R. 2005. Pocketome via comprehensive identification and classification of ligand binding envelopes. Mol. Cell. Proteomics 4:752-761.
4. Ashby, J. 1985. Fundamental structural alerts to potential carcinogenicity or noncarcinogenicity. Environ. Mutagen. 7:919-921.
5. Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., and Bourne, P.E. 2000. The Protein Data Bank. Nucleic Acids Res. 28:235-242.
6. Bisson, W.H., Cheltsov, A.V., Bruey-Sedano, N., Lin, B., Chen, J., Goldberger, N., May, L.T., Christopoulos, A., Dalton, J.T., Sexton, P.M., Zhang, X.K., and Abagyan, R. 2007. Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs. Proc. Natl. Acad. Sci. U.S.A. 104:11927-11932.
7. Bock, J.R. and Gough, D.A. 2002. A new method to estimate ligand-receptor energetics. Mol. Cell. Proteomics 1:904-910.
8. Bottegoni, G., Kufareva, I., Totrov, M., and Abagyan, R. 2008. A new method for ligand docking to flexible receptors by dual alanine scanning and refinement (SCARE). J. Comput. Aided Mol. Des. 22:311-325.
9. Carley, D.W. 2005. Drug repurposing: Identify, develop and commercialize new uses for existing or abandoned drugs. Part II. IDrugs 8:310-313.
10. Cavasotto, C.N. and Abagyan, R.A. 2004. Protein flexibility in ligand docking and virtual screening to protein kinases. J. Mol. Biol. 337:209-225.
11. Filikov, A.V., Mohan, V., Vickers, T.A., Griffey, R.H., Cook, P.D., Abagyan, R.A., and James, T.L. 2000. Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR. J. Comput. Aided Mol. Des. 14:593-610.
12. Fischer, B., Basili, S., Merlitz, H., and Wenzel, W. 2007. Accuracy of binding mode prediction with a cascadic stochastic tunnelingmethod. Proteins 68:195-204.
13. Fleischmann, R.D., Adams, M.D., White, O., Clayton, R.A., Kirkness, E.F., Kerlavage, A.R., Bult, C.J.,Tomb, J.F.,Dougherty, B.A.,Merrick, J.M., McKenney, K., Sutton, G., Fitzhugh, W., Fields, C., Gocyne, J.D., Scott, J., Shirley, R., Liu, L., Glodek, A., Kelley, J.M.,Weidman, J.F., Phillips, C.A., Spriggs, T., Hedblom, E., Cotton, M.D., Utterback, T.R., Hanna, M.C., Nguyen, D.T., Saudek, D.M., Brandon, R.C., Fine, L.D., Fritchman, J.L., Fuhrmann, J.L., Geoghagen, N.S.M., Gnehm, C.L., McDonald, L.A., Small, K.V., Fraser, C.M., Smith,H.O., andVenter, J.C. 1995. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496-512.
14. Forino, M., Johnson, S.,Wong, T.Y.,Rozanov,D.V., Savinov, A.Y., Li, W., Fattorusso, R., Becattini, B., Orry, A.J., Jung, D., Abagyan, R.A., Smith, J.W., Alibek, K., Liddington, R.C., Strongin, A.Y., and Pellecchia, M. 2005. Efficient synthetic inhibitors of anthrax lethal factor. Proc. Natl. Acad. Sci. U.S.A. 102:9499-9504.
15. Greer, J., Erickson, J.W., Baldwin, J.J., and Varney, M.D. 1994. Application of the three-dimensional structures of protein target molecules in structure-based drug design. J. Med. Chem. 37:1035-1054.
16. Hajduk, P.J., Huth, J.R., and Tse, C. 2005. Predicting protein druggability. Drug Discov. Today 10:1675-1682.
17. Hopkins, A.L. and Groom, C.R. 2002. The druggable genome. Nat. Rev. Drug Discov. 1:727-730.
18. Kleywegt, G.J. and Jones, T.A. 1994. Detection, delineation, measurement and display of cavities in macromolecular structures. Acta Crystallogr. D Biol. Crystallogr. 50:178-185.
19. Koehler, R.T., Dixon, S.L., and Villar, H.O. 1999. LASSOO: A generalized directed diversity approach to the design and enrichment of chemical libraries. J. Med. Chem. 42:4695-4704.
20. Laiken, N. and Nemethy, G. 1970. A model for the binding of flexible ligands to the surfaces of proteins and other macromolecules. II. The properties of ligand-macromolecule systems. J. Phys. Chem. 74:4431-4441.
21. Lam, P.Y., Jadhav, P.K., Eyermann, C.J., Hodge, C.N., Ru, Y., Bacheler, L.T., Meek, J.L., Otto, M.J., Rayner, M.M., Wong, Y.N., Chang, C., Weber, P., Jackson, T., Sharpe, T., and Erickson- Vitanen, S. 1994. Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. Science 263:380-384.
22. Laskowski, R.A. 1995. SURFNET: A program for visualizing molecular surfaces, cavities, and intermolecular interactions. J. Mol. Graphics 13:307-308, 323-330.
23. Laskowski, R.A., Hutchinson, E.G., Michie, A.D., Wallace, A.C., Jones, M.L., and Thornton, J.M. 1997. PDBsum: A Web-based database of summaries and analyses of all PDB structures. Trends Biochem. Sci. 22:488-490.
24. Liang, J., Edelsbrunner, H., and Woodward, C. 1998. Anatomy of protein pockets and cavities: Measurement of binding site geometry and implications for ligand design. Protein Sci. 7:1884-1897.
25. Nicola, G., Smith, C.A., and Abagyan, R. 2008. New method for the assessment of all drug-like pockets across a structural genome. J. Comput. Biol. 15:231-240.
26. Nicola, G. and Vakser, I.A. 2007. A simple shape characteristic of protein-protein recognition. Bioinformatics 23:789-792.
27. Rarey, M., Kramer, B., and Lengauer, T. 1995. Time-efficient docking of flexible ligands into active sites of proteins. Proc. Intl. Conf. Intell. Syst. Mol. Biol. 3:300-308.
28. Roche, O., Schneider, P., Zuegge, J., Guba, W., Kansy, M., Alanine, A., Bleicher, K., Danel, F., Gutknecht, E.M., Rogers-Evans, M., Neidhart, W., Stalder, H., Dillon, M., Sjogren, E., Fotouhi, N.,Gillespie, P., Goodnow, R., Harris,W., Jones, P., Taniguchi, M., Tsujii, S., von der Saal, W., Zimmermann, G., and Schneider, G. 2002. Development of a virtual screening method for identification of "frequent hitters" in compound libraries. J. Med. Chem. 45:137-142.
29. Schapira, M., Raaka, B.M., Samuels, H.H., and Abagyan, R. 2001. In silico discovery of novel retinoic acid receptor agonist structures. BMC Struct. Biol. 1:1.
30. Sun, Y., Ewing, T.J., Skillman, A.G., and Kuntz, I.D. 1998. CombiDOCK: Structure-based combinatorial docking and library design. J. Comput. Aided Mol. Des. 12:597-604.
31. Teodoro, M.L. and Kavraki, L.E. 2003. Conformational flexibility models for the receptor in structure based drug design. Curr. Pharm. Design 9:1635-1648.
32. Totrov, M. and Abagyan, R. 2008. Flexible ligand docking to multiple receptor conformations: A practical alternative. Curr. Opin. Struct. Biol. 18:178-184.
33. Westbrook, J., Feng, Z., Chen, L., Yang, H., and Berman, H.M. 2003. The Protein Data Bank and structural genomics. Nucleic Acids Res. 31:489-491.
34. Young, L., Jernigan, R.L., and Covell, D.G. 1994. A role for surface hydrophobicity in protein-protein recognition. Protein Sci. 3:717-729.